News

Experts from 13 national bodies, including seven Royal Colleges, have joined forces to launch new practical guidance to support doctors and other health professionals around valproate use in women and girls in their reproductive years.

We have carefully reviewed this court ruling, which addresses the consent of children and young people to the use of puberty suppressing drugs as part of the treatment of gender dysphoria. We consider that the ruling should not have implications for the general ethical or legal framework for childre...

We’ve made innovative adaptations to keep Paediatric diabetes on the radar during the COVID-19 pandemic to improve care and outcomes.

Paediatricians, health visitors and GPs have joined forces to produce guidance for parents who are worried about their new baby.

Two new reports have been released outlining the findings of a snapshot survey of the UK's general paediatric and neonatal services and workforce in September 2019. The reports provide a pre-COVID benchmark and give recommendations to government, service planners and other decision makers about how ...

Dr Andrea Srur, Programme Manager for the national Diabetes Quality Programme, describes the recent successes from this project and the challenges presented by the COVID-19 outbreak.

We look ahead to plans for digital growth charts, which will be available to parents and carers in 2021.

We respond to the government's announcement of this year's flu vaccination programme, which includes Year 7 for the first time.

Dr Karen Street, Assistant Officer for Mental Health and Wellbeing, responds to a new BMA report which considers the impact of COVID-19 on mental health.

Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.